Osteoporosis: Prevention and treatment in anorexia nervosa

Eating and Weight Disorders

Volumn 7, Issue 2, 2002, Pages 72-81

  Wolfert, A ^a   Mehler, P S ^a  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

Anorexia nervosa; Bisphosphonates; Bone; Calcium; Densitometry; Estrogen; Fracture; Osteoporosis

Indexed keywords

BONE DENSITY CONSERVATION AGENT; ALENDRONIC ACID; CALCITONIN; ESTROGEN; HYDROCORTISONE; PROGESTERONE; RALOXIFENE; RISEDRONIC ACID;

AMENORRHEA; ANOREXIA NERVOSA; BONE REMODELING; FEMALE; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIODENSITOMETRY; REVIEW; ANOREXIA; BODY WEIGHT; BONE BIOPSY; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FOLLOW UP; HYDROCORTISONE BLOOD LEVEL; INCIDENCE; LEAN BODY WEIGHT; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RISK FACTOR; WEIGHT REDUCTION;

AMENORRHEA; ANOREXIA NERVOSA; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; DENSITOMETRY, X-RAY; FEMALE; HUMANS; OSTEOPOROSIS;

EID: 0012983776     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03354433     Document Type: Review

References (83)

1. Shisslak C.M., Crago M., Estes L.S.: The spectrum of eating disorders. Int. J. Eat. Disord., 18, 208-219, 1995.
2. Engles J., Honnston M., Hunter D.: Increasing incidence of AN. Am. J. Psychiatry, 18, 1266-1271, 1995.
3. White CM., Hergenroeder A.C., Klish W.J.: Bone mineral density in amenorrheic 15-21 year old females. Am. J. Dis. Child., 146, 31-35, 1992.
4. Lucas A.R., Melton L.J., Crowson CS, O'Fallon W.M.: Long-term fracture risk among women with AN: a population-based cohort study. Mayo Clin. Proc, 74, 972-977, 1999.
5. Lucas A.R., Beard CM, O'Fallon W.M., Kurland L.T.: 50 year trends in the incidence of AN. Am. J. Psychiatry, 148, 917-922, 1991.
6. Brotman A.W., Stern T.A.: Osteoporosis and pathologic fractures in AN. Am. J. Psychiatry, 142, 495-496, 1985.
7. Soyka L.A., Grinspoon S., Levitsky L.L., Herzog D.B., Klibanski A.: The effects of AN on bone metabolism in female adolescents. J. Clin. Endocrinol. Metab., 84, 4489-4496, 1999.
8. Grinspoon S., Miller K., Coyle C, Krempin J., Armstrong C., Pitts S., Herzog D., Klibanski A.: Severity of osteopenia in estrogen-deficient women with AN and hypothalamic amenorrhea. J. Clin. Endocrinol. Metab., 84, 2049-2055, 1999.
9. Biller B.M., Saxe V., Herzog D.G., Rosenthal D.I., Holzman S., Klibanski A.: Mechanisms of osteoporosis in adult and adolescent women with AN. J. Clin. Endocrinol. Metab., 68, 548-554, 1989.
10. Grinspoon S., Thomas E., Pitts S., Gross E., Mickley D., Miller K., Herzog D., Klibanski A.: Prevalence and predictive factors for regional osteopenia in women with AN. Ann. Intern. Med., 133, 790-794, 2000.
11. Hay P.J., Hall A., Delahunt J.W., Harper C., Mitchell A.W., Salmond C: Investigation of osteopenia in AN. Aust. N. Z. J. Psychiatry, 23, 261-268, 1989.
12. Rigotti N.A., Nussbaum S.R., Herzog D.B., Neer R.M.: Osteoporosis in women with AN. N. Engl. J. Med., 311, 1601-1606, 1984.
13. Bachrach L.K., Guido D., Katzman D., Litt I.F., Marcus R.: Decreased bone density in adolescent girls with AN. Pediatrics, 86, 440-447, 1990.
14. Powers P.S.: Osteoporosis and eating disorders. J. Pediatr. Adolesc. Gynecol., 12, 51-57, 1999.
15. Anderson A.E., Watson T., Schlechte J.: Osteoporosis and osteopenia in men with eating disorders. Lancet, 355, 1967-1968, 2000.
16. Lennkh C, de Zwaan M., Bailer U., Strnad A., Nagy C., el-Giamal N., Wiesnagrotzki S., Vytiska E., Huber J., Kasper S.: Osteopenia in AN: specific mechanisms of bone loss. J. Psychiatr. Res., 33, 349-356, 1999.
17. Kulak CA., Bilezikian J.P.: Bone mass measurement in identification of women at risk for osteoporosis. Int. J. Fertil. Womens Med., 44, 269-278, 1999.
18. Jilka R.L., Hangoc G., Girasole G.: Increased osteoclast development estrogen loss; mediation by interleukin-1. Science, 257, 88-97, 1992.
19. Bonjour J.P., Theintz G., Buchs B., Slosman D., Rizzoli R.: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J. Clin. Endocrinol. Metab., 73, 555-563, 1991.
20. Grinspoon S., Gulick T., Askari H., Landt M., Lee K., Anderson E., Ma Z., Vignati L., Bowsher R., Herzog D., Klibanski A.: Serum leptin levels in women with AN. J. Clin. Endocrinol. Metab., 81, 3861-3863, 1996.
21. Counts B., Gwirtsman H., Carlsson L.: The effect of AN on growth hormone-binding protein and insulin-like growth factor's (IGFs) and binding proteins. J. Clin. Endocrinol. Metab., 75, 762-767, 1992.
22. Mehler P.S.; Donahue T. Eckel R.: Leptin levels in AN. Int. J. Eat. Disord., 26, 189-194, 1999.
23. Mundy G.R. Secondary osteoporosis: the potential relevance of leptin and low body weight. Ann. Intern. Med., 133, 828-830, 2000.
24. Boyar R., Hellman L., Roffuarg G.: Cortisol secretion in AN. N. Engl. J. Med., 296, 190-194, 1997.
25. Newman M.M., Halmi K.A.: Relationship of bone density to estradiol and Cortisol in AN. Psychiatry Res., 29, 105-112, 1989.
26. Gold P.W., Guirstman H., Augerinus C: Abnormal hypothalamic-pituitary function in AN. N. Engl. J. Med., 314, 1335-1341, 1986.
27. Delany A.M., Dong Y., Canalis E.: Mechanisms of glucocorticoid action in bone cells. J. Cell. Biochem., 56, 295-302, 1994.
28. Golden N., Shenker I.: Amenorrhea in AN; neuroendocrine control of hypothalamic dysfunction. Int. J. Eat. Disord., 16, 53-59, 1994.
29. Warren M.P.: Amenorrhea in endurance runners. J. Clin. Endocrinol. Metab., 75, 1393-1398, 1992.
30. Frish R.E., Réveile R., Cook S.: Components of weight at menarche: estimated total water, lean body weight and fat. Hum. Biol., 45, 469-483, 1973.
31. Katz M.G., Vollenhoven B.: The reproductive endocrine consequences of AN. Br. J. Obstet. Gynaecol., 107, 707-713, 2000.
32. Swerdloff R.S., Wang C: Androgens, estrogens and bone in men. Ann. Intern. Med., 133, 1002-1004, 2000.
33. Rigotti N.A., Neer R.M., Skates S.J., Herzog D.B., Nussbaum S.R.: The clinical course of osteoporosis in AN. A longitudinal study of cortical bone mass. JAMA, 265, 1133-1138, 1991.
34. Anderson A.E., Woodward PJ, LaFrance N.: Bone mineral density of eating disorder subgroups. Int J. Eat. Disord., 18, 335-342, 1995.
35. Iketani T., Kiriike N., Nakanishi S., Nakasuji T.: Effects of weight gain and resumption of menses on reduced bone density in patients with AN. Biol. Psychiatry, 37, 521-527, 1995.
36. Ward A., Brown N., Treasure J.: Persistent osteopenia after recovery from AN. Int. J. Eat. Disord., 22, 71-75, 1997.
37. Prior J.C., Vigna Y.M., Schechter M.T., Burgess A.E.: Spinal bone loss and ovulatory disturbances. N. Engl. J. Med., 323, 1221-1227, 1990.
38. Hergenroeder A.C.: Bone mineralization hypothalamic amenorrhea and sex steroid therapy in female adolescents. J. Pediatr., 126, 683-689, 1995.
39. Cauley J.A., Gutni J.P., Kuller L.H.: Differences in serum sex hormones and bone mineral density. Am. J. Epidemiol., 139, 1035-1046, 1994.
40. Goebel G., Schweiger U., Kruger R., Fichter M.M.: Predictors of bone mineral density in patients with eating disorders. Int. J. Eat. Disord., 25, 143-150, 1999.
41. Grinspoon S., Baum H., Lee K., Anderson E., Herzog D., Klibaski A.: Effect of short-term insulin-like growth factor administration on bone turnover in AN. J. Clin. Endocrinol. Metab., 81, 3864-3870, 1996.
42. Hotta M., Fukuda I., Sato K., Hizuka N., Takano K.: The relationship between bone-turnover and body weight, serum insulinlike growth factor and serum IGF-binding protein levels in patient with AN. J Clin. Endocrinol. Metab., 85, 200-206, 2000.
43. De Crée C: Sex steroid metabolism and menstrual irregularities in the exercising female. Sports Med., 25, 369-406, 1998.
44. National osteoporosis foundation.: Physicians guide to prevention and treatment of osteoporosis. Bell Mead, NJ, Excerpta Media, 1998.
45. Cummings S.R., Black D.M., Nevitt M.C.: Bone density at various sites for prediction of hip fracture. Lancet, 341, 72-75, 1993.
46. Bauer D.C., Gluer C.C., Cauley J.A., Vogt T.M., Ensrud K.E., Genant H.K., Black D.M.: Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of osteoporotic fractures Research Group. Arch. Intern. Med., 157, 629-634, 1997.
47. Kanis J.A., and the WHO Study Group: Assessment of fracture risk and its application for screening post-menopausal osteoporosis. Osteoporos. Int., 4, 368-381, 1994.
48. Mehler P.S., Andersen A.E.: Eating Disorders: A guide to medical care and complications, The Johns Hopkins University Press, Baltimore, 2000.
49. Maugars Y.M., Berthelot J.M., Forrestier R., Mammar N., Lalande S., Venisse J.L., Prost A.M.: Follow-up of bone mineral density in 27 cases of AN. Eur. J. Endocrinol., 135, 591-597, 1996.
50. Cummings S.R., Palermo L., Browner W., Marcus R., Wallace R., Pearson J., Blackwell T., Eckert S., Black D.: Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. JAMA 283, 1318-1321, 2000.
51. Zipfel S., Lowe B., Peter H.C., Herzog W.: Long-term prognosis in AN, lessons from a 21-year follow up study. Lancet, 283, 1318-1321, 2000.
52. Sullivan P.F., Bulik CM, Fear J.L., Pickering A.: AN: a 12-year follow up study. Am. J. Psychiatry, 155, 934-946, 1998.
53. Wong J.C.H., Lewindon P., Mortinsen R.: Bone mineral density in adolescents with recently diagnosed AN. Int. J. Eat. Disord., 29, 11-16, 2001.
54. Heaney R.P.: Pathophysiology of osteoporosis. Endocrinol. Metab. Clin. North Am., 27, 255-265, 1998.
55. Klibanski A., Biller B.M., Schoenfeld D.A., Herzog D.B., Saxe V.C.: The effects of estrogen administration on trabecular bone loss in young women with AN. J. Clin. Endocrinol. Metab., 80, 898-904, 1995.
56. Bachrach L.K., Katzman D.K., Litt I.F., Guido D., Marcus R.: Recovery from osteopenia in adolescent girls with AN. J. Clin. Endocrinol. Metab., 72, 602-606, 1991.
57. Baker D., Roberts R., Towell T.: Factors predictive of bone mineral density in eating-disordered women: a longitudinal study. Int. J. Eat. Disord., 27, 29-35, 2000.
58. Siemers B., Chakmakjian Z., Gench B.: Bone density patterns in women with AN. Int. J. Eat. Disord., 19, 179-186, 1996.
59. Sieman E., Wahner H.W., Offord K.P., Johnson W.J., Riggs B.L.: Differential effects of appendicular skeleton. J. Clin. Invest., 102, 1302-1313, 1982.
60. Davies K.M., Pearson P.H., Huseman CA, Greger N.G., Kimmel D.K., Recker R.R.: Reduced bone mineral in patients with eating disorders. Bone, 11, 143-147, 1990.
61. Kotier L., Katz L., Anyan W., Comite F.: Case study of the effects of prolonged and severe AN on bone mineral density. Int. J. Eat. Disord., 15, 395-399, 1994.
62. Golden N.H., Jacobson M.S., Schebendach J., Solanto M.V., Hertz S.M., Shenker I.R.: Resumption of menses in AN. Arch. Pediatr. Adolesc. Med., 151, 16-21, 1997.
63. Bone H.G., Greenspan S.L., Bell N., Miller S.S., Yates A.J., Lombardi A.: Alendronate and estrogen effect in postmenopausal women with low bone density. J. Clin. Endocrinol. Metab., 85, 720-726, 2000.
64. Hergenroeder A.C., Smith E.O., Shypailo R., Jones L.A., Klish W.J., Ellis K.: Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am. J. Obstet. Gynecol., 176, 1017-1025, 1997.
65. Cumming D.C.: Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch. Intern. Med., 156, 2193-2195, 1996.
66. Iketani T., Kiriike N., Nakanishi S., Nakasuji T.: Effect of weight gain and resumption of menses on reduced bone density in AN. Biol. Psychiatry, 37, 521-527, 1998.
67. Karlsson M.K., Weigall S.J., Duan Y., Seeman E.: Bone size and volumetric density in women with AN receiving estrogen replacement therapy and in women recovered from AN. J. Clin. Endocrinol. Metab., 85, 3177-3182, 2000.
68. Carmicheal K.A., Carmicheal D.H.: Bone metabolism and osteopenia in eating disorders. Medicine, 74, 254-267, 1995.
69. Naganathan V., Jones G., Nicholson G., Eisman J., Sambrook P.N.: Vertebral fracture risk with long-term corticosteroid therapy. Arch. Intern. Med., 160, 2917-2922, 2000.
70. Buckley L., Leib E.S., Cartularo K.S., Vacek P.M., Cooper S.M.: Calcium and vitamin D supplementation prevents bone loss in the spine secondary to corticosteroids in patients with rheumatoid arthritis. Ann. Intern. Med., 125, 961-968, 1996.
71. Adachi J.D., Bensen W.G., Brown J., Hanley D., Hodsman D., Josse R., Kendler D.L., Lentle B., Olszynski W., Ste-Marie L.G., Tenenhouse A., Chines A.A.: Intermittent etidronate therapy to prevent corticos-teroid-induced osteoporosis. N. Engl. J. Med., 337, 382-387, 1997.
72. Sundgot-Borgen J., Bahr R., Falch J.A., Schneider L.S.: Normal bone mass in bulimic women. J. Clin. Endocrinol. Metab., 83, 3144-3149, 1998.
73. Greenspan S.L.: A 73-year-old women with osteoporosis. JAMA, 281, 1531-1540, 1999.
74. Recker R.R., Hinders S., Davies K.M., Heaney R.P., Stegman M.R., Lappe J.M., Kimmel D.B.: Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J. Bone Miner. Res., 11, 1961-1966, 1996.
75. Chapuy M., Arlot M.E., Delmas P., Meunier PJ.: Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. B. Med. J., 308, 1081-1082, 1994.
76. Deal C: Can calcium and vitamin D supplementation adequately treat patients with osteoporosis? Cleve. Clin. J. Med., 10, 696-698, 2000.
77. Lloyd T.: Oral contraceptive use by teenage women does not affect peak bone mass. Fertil. Steril., 74, 734-738, 2000.
78. Ettinger B., Black D.M., Mitlak B.H.: Reduction of vertebral risk-factor in postmenopausal women with osteoporosis treated with raloxifene. JAMA, 282, 637-645, 1999.
79. rd, Gennari C, Christiansen C, Arnaud CD., Delmas P.D.: Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women. Arch. Intern. Med., 160, 3444-3450, 2000.
80. Riggs B.L., Melton L.J., O'Fallon W.M.: Drug therapy for vertebral fractures in osteoporosis. Bone, 18, 197-201, 1996.
81. Bone H.G., Greenspan S.L., McKeever C., Bell N., Davidson M., Downs R.W., Emkey R., Meunier P.J., Miller S.S., Mulloy A.L., Recker R.R., Weiss S.R., Heyden N., Musliner T., Suryawanshi S., Yates A.J., Lombardi A.: Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen study group. J. Clin. Endocrinol. Metab., 85, 720-726, 2000.
82. Schnitzer T., Bone H.G., Kiel D., Levine MA, Yates J., Orloff J.J.: Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging Clin. Exp. Res., 12, 1-12, 2000.
83. Mehler P.S.: Diagnosing and caring for patients with AN in primary care settings. Ann. Intern. Med., 134, 1048-1059, 2001.